Sign In
Buy CMPS
$12.69
-0.640 (-4.80%)
At Close: Jun 03, 2026
These 3 Psychedelic Stocks Activated After Trump's Executive Order
11:15am, Monday, 27'th Apr 2026
The Trump administration's April 2026 executive order in support of psychedelic drugs may have flown under the radar for many investors in the midst of the Iran war and numerous other high-profile dom
Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year?
10:41am, Friday, 24'th Apr 2026
Here is how COMPASS Pathways PLC Sponsored ADR (CMPS) and DBV Technologies S.A. (DBVT) have performed compared to their sector so far this year.
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher
10:37am, Friday, 24'th Apr 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Trump Backs Psychedelics. Here's 1 Company Investors Need to Know About
09:50pm, Thursday, 23'rd Apr 2026
Compass Pathways is already in the final stage of development on a psychedelic medicine to treat depression.
What Makes COMPASS Pathways PLC Sponsored ADR (CMPS) a Strong Momentum Stock: Buy Now?
01:01pm, Wednesday, 22'nd Apr 2026
Does COMPASS Pathways PLC Sponsored ADR (CMPS) have what it takes to be a top stock pick for momentum investors? Let's find out.
How Much Upside is Left in COMPASS Pathways (CMPS)? Wall Street Analysts Think 136%
10:56am, Wednesday, 22'nd Apr 2026
The mean of analysts' price targets for COMPASS Pathways (CMPS) points to a 136% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among
Compass Pathways: Red Hot Psychedelic Market For Pioneer With Near Term Psychedelic Filing In TRD
11:45am, Tuesday, 21'st Apr 2026
Compass Pathways plc (CMPS) has faced significant risks since my last 'Buy' rating in January 2026. CMPS shares had declined approximately 10% over the intervening months, but then registered huge gai
FTSE 100 Live: London stocks slide as aerospace and defence sector falls
09:48am, Tuesday, 21'st Apr 2026
FTSE 100 down 35 points at 10,574 Markets await confirmation of US-Iran talks UK bond eyes developments in Westminster AB Foods, British Land,...
Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments
06:30am, Tuesday, 21'st Apr 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced toda
This 4/20, Wall Street Is Betting on More Than Marijuana
03:05pm, Monday, 20'th Apr 2026
While many investors focused on the annual 4/20 holiday, expecting the usual buzz around marijuana stocks, a quiet revolution was unfolding in Washington. Over a weekend when most of the market was lo
How Trump's psychedelics executive order could unlock stalled cannabis reform
02:05pm, Monday, 20'th Apr 2026
The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and ibogaine. The order does not change their legal status,
Why Compass Pathways Stock Rocketed 40% Today
12:02pm, Monday, 20'th Apr 2026
Compass Pathways has already reported two positive phase 3 trials for treatment-resistant depression (TRD). The company's COMP360 synthetic psilocybin treatment could now be on a faster track for appr
Compass Pathways: The Bull Case Is Early, Not Wrong
11:26am, Monday, 20'th Apr 2026
COMPASS Pathways plc is developing pharmaceutical-grade psilocybin treatments for severe mental health conditions, notably treatment-resistant depression. CMPS remains a pipeline-stage biotech with no
Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar
11:07am, Monday, 20'th Apr 2026
The FDA will fast-track certain psychedelic treatments. Several biotech stocks are soaring due to the new policy.
Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026
06:30am, Monday, 20'th Apr 2026
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
